Concord Biotech Quarterly Results for Trading Insights
CONCORDBIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹63 Cr
QSept 2025
Concord Biotech Quarterly Results Key Highlights
- Revenue of ₹263 Cr in Sept 2025 (-40.1% vs Mar 2025, -17.8% vs Sept 2024)
- Net Profit of ₹63 Cr in Sept 2025 (-55.0% vs Mar 2025, -34.4% vs Sept 2024)
- EBITDA of ₹104 Cr in Sept 2025 (-47.5% vs Mar 2025)
- Operating Margin of 36.0% in Sept 2025 (-8.0pp vs Mar 2025)
- Earnings Per Share of ₹6.03 in Sept 2025 (-55.1% vs Mar 2025)
Concord Biotech Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 263 | 439 | 219 | 288 | 320 | -40.1% | -17.8% |
| Net Profit (₹ Cr) | 63 | 140 | 44 | 64 | 96 | - | - |
| EBITDA (₹ Cr) | 104 | 198 | 77 | 105 | 144 | - | - |
| EPS (₹) | 6.03 | 13.42 | 4.21 | 6.08 | 9.15 | - | - |
| Operating Margin (%) | 36.0% | 44.0% | 30.0% | 34.0% | 43.0% | - | - |
Concord Biotech Share Price Trend Around Quarterly Results
Visualize Concord Biotech's 1-year price movement across quarterly results — ideal for logging trades in Concord Biotech share price
chart using Tickjournal. All values in ₹.
Related Pages for Concord Biotech
Additional stock information and data for CONCORDBIO
Revenue Trend (₹ Cr)
Dec 2025
288
Jun 2025
219
Mar 2025
439
Sept 2025
263
Net Profit Trend (₹ Cr)
Dec 2025
64
Jun 2025
44
Mar 2025
140
Sept 2025
63
Operating Margin Trend (%)
Dec 2025
34.0%
Jun 2025
30.0%
Mar 2025
44.0%
Sept 2025
36.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Concord Biotech quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores